Multiregional analysis of combined hepatocellular-cholangiocarcinoma reveals histologic diversity and molecular clonality

被引:3
|
作者
Na, Hee Young [1 ]
Kim, Jee Hyun [2 ]
Kim, Haeryoung [3 ]
Cho, Jai Young [4 ]
Han, Ho-Seong [4 ]
Jang, Eun Sun [5 ]
Kim, Jin-Wook [5 ]
Jeong, Sook-Hyang [5 ]
Heo, Jayoon [2 ,6 ]
Kim, Ji-Won [2 ]
Kim, Jin Won [2 ]
Ahn, Soomin [1 ,7 ,8 ]
机构
[1] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Coll Med, Seongnam, South Korea
[2] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Hematol & Med Oncol,Bundang Hosp, Seongnam, South Korea
[3] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul Natl Univ Hosp, Seoul, South Korea
[4] Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Surg, Seongnam, South Korea
[5] Seoul Natl Univ, Coll Med, Dept Internal Med, Div Gastroenterol,Bundang Hosp, Seongnam, South Korea
[6] Ilsan Hosp, Dept Internal Med, Natl Hlth Insurance Serv, Goyang, South Korea
[7] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol & Translat Genom, Seoul, South Korea
[8] Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol & Translat Genom, Sch Med, 81 Irwon ro, Seoul 06351, South Korea
关键词
combined hepatocellular-cholangiocarcinoma; intermediate cell carcinoma; liver; next-generation sequencing; CARCINOMA;
D O I
10.1111/his.15081
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Combined hepatocellular-cholangiocarcinoma (cHCC-CC) is a rare type of liver tumour that exhibits both hepatocytic and biliary differentiation within the same tumour. The histology and genomic alterations of recurrent/metastatic cHCC-CC are poorly understood. We selected six patients with cHCC-CC whose recurrent or metastatic tumours were histologically confirmed. Four patients with classic cHCC-CCs and two with intermediate cell carcinomas (ICs) were included. The clinicopathological features were evaluated, and next-generation sequencing was performed in 17 multiregional and longitudinal tumour samples. The histology of recurrent/metastatic lesions of classic cHCC-CCs was variable: hepatocellular carcinoma (HCC) was observed in one (25.0%) patient, cHCC-CC in one (25.0%) patient, and cholangiocarcinoma (CC) in two (50.0%) patients. Among 13 samples from four classic cHCC-CC patients, the most frequent pathological variants were TP53 (46.2%), TERT promoter (38.5%), ARID1A mutations (23.1%), and MET amplification (30.8%). In the sequencing analysis of each HCC and CC component, three (75.0%) of the four classic cHCC-CCs shared pathogenic variants. A large proportion of mutations, both pathogenic and those of undetermined significance, were shared by each HCC and CC component. Regarding ICs, the ATM mutation was detected in one patient. In conclusion, the histology of recurrent/metastatic cHCC-CCs was heterogeneous. Genomic profiling of classic cHCC-CCs revealed similar genomic alterations to those of HCC. Considerable overlapping genomic alterations in each HCC and CC component were observed, suggesting a monoclonal origin. Genetic alterations in ICs were different from those in either HCC or CC, suggesting the distinct nature of this tumour. The histology of recurrent/metastatic tumours of cHCC-CCs was variable. Genomic profiling of cHCC-CC revealed considerable overlapping genomic alterations in each HCC and CC component.image
引用
收藏
页码:402 / 408
页数:7
相关论文
共 50 条
  • [31] A HISTOCHEMICAL-STUDY ON COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
    UEKUSA, T
    MASTUMOTO, T
    ABE, H
    FUKUDA, Y
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1985, 18 (06) : 673 - 673
  • [32] Epigenetic regulation of combined hepatocellular-cholangiocarcinoma subtypes
    Schachtschneider, Kyle M.
    Lokken, Ryan Peter
    Huang, Yu-Hui
    Guzman, Grace
    Schook, Lawrence B.
    Gaba, Ron C.
    CANCER RESEARCH, 2019, 79 (13)
  • [33] EVIDENCE FOR A HEPATOCELLULAR LINEAGE IN A COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA OF TRANSITIONAL TYPE
    FISCHER, HP
    DOPPL, W
    OSBORN, M
    ALTMANNSBERGER, M
    VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1988, 56 (02) : 71 - 76
  • [34] Breast Metastasis From a Combined Hepatocellular-Cholangiocarcinoma
    Silva, Marco
    Coelho, Rosa
    Rios, Elisabete
    Gomes, Sara
    Carneiro, Fatima
    Macedo, Guilherme
    ACG CASE REPORTS JOURNAL, 2019, 6 (04)
  • [35] A HISTOCHEMICAL-STUDY ON COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
    UEKUSA, T
    MASTUMOTO, T
    ABE, H
    FUKUDA, Y
    ACTA HISTOCHEMICA ET CYTOCHEMICA, 1987, 20 (06) : 737 - 737
  • [36] Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management
    Ye, Liangtao
    Schneider, Julia S. S.
    Ben Khaled, Najib
    Schirmacher, Peter
    Seifert, Carolin
    Frey, Lea
    He, Yulong
    Geier, Andreas
    De Toni, Enrico N. N.
    Zhang, Changhua
    Reiter, Florian P. P.
    LIVER CANCER, 2024, 13 (01) : 6 - 28
  • [37] Analysis of viral integration reveals new insights of oncogenic mechanism in HBV-infected intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma
    Linghao Zhao
    Yuyouye Wang
    Tao Tian
    Xinjie Rao
    Wei Dong
    Jinmin Zhang
    Yuan Yang
    Qifei Tao
    Fang Peng
    Chenhang Shen
    Songbo Wang
    Hui Liu
    Xi Zeng
    Weiping Zhou
    Hepatology International, 2022, 16 : 1339 - 1352
  • [38] Co-occurrence of hepatocellular carcinoma and combined hepatocellular-cholangiocarcinoma
    Suren, D.
    Yildirim, M.
    INDIAN JOURNAL OF CANCER, 2015, 52 (04) : 622 - +
  • [39] Combined hepatocellular-cholangiocarcinoma: a population level analysis of incidence and mortality trends
    Wang, Jiakun
    Li, Enliang
    Yang, Hao
    Wu, Junjun
    Lu, Hong cheng
    Yi, Chenhao
    Lei, Jun
    Liao, Wenjun
    Wu, Linquan
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2019, 17 (1)
  • [40] Clinicopathologic Analysis of Combined Hepatocellular-Cholangiocarcinoma According to the Latest WHO Classification
    Akiba, Jun
    Nakashima, Osamu
    Hattori, Satoshi
    Tanikawa, Ken
    Takenaka, Miki
    Nakayama, Masamich
    Kondo, Reiichiro
    Nomura, Yoriko
    Koura, Keiko
    Ueda, Kousuke
    Sanada, Sakiko
    Naito, Yoshiki
    Yamaguchi, Rin
    Yano, Hirohisa
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2013, 37 (04) : 496 - 505